Kate Haviland's Net Worth
Kate Haviland's net worth is estimated to be at least $9,068,211.11 as of 11/23/2024. CoreStreet's estimation of Kate Haviland's net worth is based on their sale of stock and current holding of stock.
Kate Haviland is CEO at Blueprint Medicines Corp. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 12,464 units of BPMC stock on 03/07/2024. Their biggest sale was on 03/01/2019 when they sold 21,644 units of Blueprint Medicines Corp stock for $1,840,822.20. They typically trade 2 times per year.
Total value of insider buys:
- $48,378.00
Total value of insider sells:
- $9,019,833.11
Most recent insider trade:
- March 7, 2024
Kate Haviland's Insider Trading History
| Blueprint Medicines Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 7, 2024 | CEO | 12,464 | $90.69 | Sell | $1,130,360.16 |
March 6, 2023 | CEO | 6,640 | $45.69 | Sell | $303,381.60 |
Nov. 3, 2022 | CEO | 1,100 | $43.98 | Buy | $48,378.00 |
Dec. 13, 2021 | COO | 1,000 | $98.30 | Sell | $98,300.00 |
June 28, 2021 | COO | 1,000 | $90.24 | Sell | $90,240.00 |
Oct. 16, 2020 | COO | 13,334 | $101.23 | Sell | $1,349,800.82 |
Sept. 22, 2020 | COO | 3,143 | $85.49 | Sell | $268,695.07 |
Jan. 10, 2020 | COO | 7,763 | $85.16 | Sell | $661,097.08 |
Aug. 19, 2019 | COO | 95 | $85.00 | Sell | $8,075.00 |
July 16, 2019 | COO | 1,571 | $95.47 | Sell | $149,983.37 |
June 17, 2019 | COO | 11,952 | $96.46 | Sell | $1,152,889.92 |
March 1, 2019 | COO | 21,644 | $85.05 | Sell | $1,840,822.20 |
Feb. 12, 2018 | Insider | 6,775 | $74.93 | Sell | $507,650.75 |
Oct. 5, 2017 | Insider | 5,449 | $66.44 | Sell | $362,031.56 |
Sept. 18, 2017 | Insider | 6,356 | $60.03 | Sell | $381,550.68 |
July 5, 2017 | Insider | 7,265 | $54.66 | Sell | $397,104.90 |
June 28, 2017 | Insider | 6,357 | $50.00 | Sell | $317,850.00 |